Difference between revisions of "Klatte T, et al. J. Urol. (2010) cited as Ref 729 in DOI: 10.1038/s41392-020-0110-5 (Q9992)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 183, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 2403-2408, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome (English) | ||
| Property / title: Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 2403-2408 | ||
| Property / Page(s): 2403-2408 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Klatte T, et al. J. Urol. (2010) cited as Ref 729 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Klatte T
0 references
2010
0 references
J. Urol.
0 references
183
0 references
Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome (English)
0 references
2403-2408
0 references
